- World rank, all time
- #28,914 of 42,892
- Rank in United States
- #6,188 of 8,685
- Research works
- 125 ▲ 25% vs 2013–17
- Citations
- 8.4k 67.0 per fractional work
- Top-10% rate
- 10.8% record average 16.5%
- Open access
- 45% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 8.9×. Every wedge is a field page.
- Dentistry 8.9×
- Immunology and Microbiology 4.9×
- Biochemistry, Genetics and Molecular Biology 4.6×
- Medicine 2.5×
- Nursing 2.0×
- Environmental Science 1.3×
- Chemistry 0.6×
- Materials Science 0.6×
- Health Professions 0.4×
- Computer Science 0.3×
- Decision Sciences 0.3×
- Engineering 0.2×
- Economics, Econometrics and Finance 0.2×
Who are the top researchers at FibroGen (United States)?
Ranked on the composite score, Lee A. Flippin lead among researchers whose main affiliation is FibroGen (United States).
- 1 Lee A. Flippin United States · #488,475 worldwide 123 citations · 17 works
Which keywords describe research at FibroGen (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Fibrosis, Angiogenesis, TGF-ß Signaling, Cancer Progression, Wound Healing, Matricellular Proteins, Cell Adhesion and Regulation of Gene Expression.
- High Altitude
- Adaptation
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Pulmonary Hypertension
- Pulmonary Involvement
- Autoantibodies
- Endothelial Dysfunction
- Hypoxia-Inducible Factors
- Warburg Effect
- Cancer Treatment
- Oxidative Stress
- Iron Deficiency
- Anemia
- Cardiovascular Disease
- CCN Family
- Regulation of Gene Expression
- Matricellular Proteins
- Cancer Progression
- Angiogenesis
- Fibrosis
- TGF-ß Signaling
- Wound Healing
- Cell Adhesion
- Connective Tissue Growth Factor
- Inflammation
- Chronic Kidney Disease
- Tumor Microenvironment
- Heart Failure
- Neuroprotection
- HIF-1
- Erythropoiesis-Stimulating Agents
- Treatment
- Cancer
- Immunosuppressive Therapy
- Systemic Sclerosis
- Epithelial-Mesenchymal Transition
- Metastasis
- Interstitial Lung Disease
- Biomaterials
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Fibrosis24▲ 99×7 topics
- Angiogenesis21▲ 41×11 topics
- TGF-ß Signaling20▲ 226×3 topics
- Cancer Progression19▲ 66×5 topics
- Wound Healing16▲ 56×6 topics
- Matricellular Proteins15▲ 493×2 topics
- Cell Adhesion15▲ 139×2 topics
- Regulation of Gene Expression15▲ 243×2 topics
- Connective Tissue Growth Factor14▲ 457×2 topics
- CCN Family14▲ 1507×1 topic
- Inflammation12▲ 4.1×36 topics
- Cardiovascular Disease12▲ 8.2×8 topics
- Chronic Kidney Disease11▲ 37×8 topics
- Anemia10▲ 72×4 topics
- Tumor Microenvironment10▲ 22×5 topics
- Iron Deficiency9▲ 130×2 topics
- Heart Failure9▲ 16×8 topics
- Oxidative Stress9▲ 3.9×21 topics
- Neuroprotection9▲ 19×5 topics
- Cancer Treatment8▲ 26×4 topics
- HIF-18▲ 89×1 topic
- Warburg Effect8▲ 89×1 topic
- Erythropoiesis-Stimulating Agents8▲ 433×1 topic
- Hypoxia-Inducible Factors8▲ 433×1 topic
- Treatment7▲ 4.4×10 topics
- Endothelial Dysfunction6▲ 18×4 topics
- Cancer6▲ 3.3×17 topics
- Autoantibodies5▲ 18×3 topics
- Immunosuppressive Therapy5▲ 22×3 topics
- Pulmonary Involvement5▲ 128×1 topic
- Systemic Sclerosis5▲ 128×1 topic
- Pulmonary Hypertension4▲ 21×3 topics
- Epithelial-Mesenchymal Transition4▲ 37×2 topics
- TGF-ß4▲ 18×3 topics
- Metastasis4▲ 9.0×5 topics
- Idiopathic Pulmonary Fibrosis4▲ 73×1 topic
- Interstitial Lung Disease4▲ 52×1 topic
- Adaptation4▲ 9.6×1 topic
- Biomaterials4▲ 14×4 topics
- High Altitude4▲ 150×1 topic
Which research topics does FibroGen (United States) publish most on?
By volume in 2022–2025: Erythropoietin and Anemia Treatment, Hemoglobinopathies and Related Disorders, Systemic Sclerosis and Related Diseases and Glycosylation and Glycoproteins Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Erythropoietin and Anemia Treatment Hematology 1 works
- 2 Hemoglobinopathies and Related Disorders Genetics 1 works
- 3 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 4 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 5 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 6 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 7 Galectins and Cancer Biology Immunology 0 works
- 8 Connective Tissue Growth Factor Research Molecular Biology 0 works
- 9 Oral and Maxillofacial Pathology Oral Surgery 0 works
- 10 High Altitude and Hypoxia Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has FibroGen (United States)'s research output changed?
Output in 2018–2022 was 25% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.